Showing results (31-40 of 240) with videos related to

Sort By:
Pageof 24
Annals of Surgical Oncology|March 31, 2022
Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma?Kevin M Turner, Aaron M Delman, Allison M Ammann, et al.
The Journal of Surgical Research|June 10, 2014
Validation of the University HealthSystem Consortium administrative dataset: concordance and discordance with patient-level institutional dataJeffrey M Sutton, Anthony J Hayes, Gregory C Wilson, et al.
Annals of Surgical Oncology|February 10, 2022
Systemic Therapy for Resected Pancreatic Adenocarcinoma: How Much is Enough?Kevin M Turner, Aaron M Delman, Dennis M Vaysburg, et al.
Surgery|September 21, 2014
High readmission rates after surgery for chronic pancreatitisAlexander V Fisher, Jeffrey M Sutton, Gregory C Wilson, et al.
Annals of Surgical Oncology|June 19, 2026
Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal AdenocarcinomaPaul H McClelland, Megan A Satyadi, Ryan P Johnson, et al.
Annals of Surgical Oncology|April 5, 2015
Readmission After Pancreaticoduodenectomy: The Influence of the Volume Effect Beyond MortalityJeffrey M Sutton, Gregory C Wilson, Koffi Wima, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 22, 2014
Cost effectiveness after a pancreaticoduodenectomy: bolstering the volume argumentJeffrey M Sutton, Gregory C Wilson, Ian M Paquette, et al.
The Surgical Clinics of North America|September 5, 2024
Neoadjuvant and Adjuvant Therapy in Resectable Pancreatic AdenocarcinomaRyan Johnson, Paul H McClelland, Syed A Ahmad
Cancer Treatment and Research|December 6, 2017
Repeat Hepatectomy for Colorectal Liver MetastasesVikrom Dhar, Ryan M Thomas, Syed A Ahmad
Surgery|July 25, 2016
The natural history of chronic pancreatitis after operative intervention: The need for revisional operationVikrom K Dhar, Nick C Levinsky, Brent T Xia, et al.
Pageof 24